BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Spitalieri P, Talarico VR, Murdocca M, Novelli G, Sangiuolo F. Human induced pluripotent stem cells for monogenic disease modelling and therapy. World J Stem Cells 2016; 8(4): 118-135 [PMID: 27114745 DOI: 10.4252/wjsc.v8.i4.118]
URL: https://www.wjgnet.com/1948-0210/full/v8/i4/118.htm
Number Citing Articles
1
Elvira Smeralda Famulari, Victor Navarro-Tableros, Maria Beatriz Herrera Sanchez, Giulia Bortolussi, Marta Gai, Laura Conti, Lorenzo Silengo, Emanuela Tolosano, Ciro Tetta, Andrés Fernando Muro, Giovanni Camussi, Sharmila Fagoonee, Fiorella Altruda. Human liver stem cells express UGT1A1 and improve phenotype of immunocompromised Crigler Najjar syndrome type I miceScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-57820-2
2
Winston W.-Y. Kao, Vivien J. Coulson-Thomas. Cell Therapy of Corneal DiseasesCornea 2016; 35(Supplement 1): S9 doi: 10.1097/ICO.0000000000001010
3
D. Tavian, S. Missaglia, M. Castagnetta, D. Degiorgio, E.M. Pennisi, R.A. Coleman, P. Dell'Era, C. Mora, C. Angelini, D.A. Coviello. Generation of induced Pluripotent Stem Cells as disease modelling of NLSDMMolecular Genetics and Metabolism 2017; 121(1): 28 doi: 10.1016/j.ymgme.2017.03.009
4
Dharmendra Kumar, Taruna Anand, Wilfried A. Kues. Clinical potential of human-induced pluripotent stem cellsCell Biology and Toxicology 2017; 33(2): 99 doi: 10.1007/s10565-016-9370-9
5
Noriko Watanabe, Katherine E Santostefano, Anthony T Yachnis, Naohiro Terada. A pathologist’s perspective on induced pluripotent stem cellsLaboratory Investigation 2017; 97(10): 1126 doi: 10.1038/labinvest.2017.81
6
Paola Spitalieri, Rosa V. Talarico, Michela Murdocca, Luana Fontana, Marzia Marcaurelio, Elena Campione, Roberto Massa, Giovanni Meola, Annalucia Serafino, Giuseppe Novelli, Federica Sangiuolo, Annalisa Botta. Generation and Neuronal Differentiation of hiPSCs From Patients With Myotonic Dystrophy Type 2Frontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.00967
7
Solveig Lena Hansen, Clemens Heyder, Claudia Wiesemann. Die klinische Anwendung von humanen induzierten pluripotenten StammzellenVeröffentlichungen des Instituts für Deutsches, Europäisches und Internationales Medizinrecht, Gesundheitsrecht und Bioethik der Universitäten Heidelberg und Mannheim 2020; 48: 197 doi: 10.1007/978-3-662-59052-2_7
8
S. Dinarelli, M. Girasole, P. Spitalieri, R.V. Talarico, M. Murdocca, A. Botta, G. Novelli, R. Mango, F. Sangiuolo, G. Longo. AFM nano-mechanical study of the beating profile of hiPSC-derived cardiomyocytes beating bodies WT and DM1Journal of Molecular Recognition 2018; 31(10): e2725 doi: 10.1002/jmr.2725
9
Nelisa LAÇİN TÜRKOĞLU, Nevra CESUR. İndüklenmiş Pluripotent Kök Hücrelerin Elde Edilmesi ve Rejeneratif Tıpta UygulanabilirliğiUludağ Üniversitesi Tıp Fakültesi Dergisi 2021;  doi: 10.32708/uutfd.801247
10
Juan Diego Naranjo, Michelle E Scarritt, Luai Huleihel, Anjani Ravindra, Crisanto M Torres, Stephen F Badylak. Regenerative Medicine: lessons from Mother NatureRegenerative Medicine 2016; 11(8): 767 doi: 10.2217/rme-2016-0111
11
Maria S. Collado, Banumathi K. Cole, Robert A. Figler, Mark Lawson, David Manka, Michael B. Simmers, Steve Hoang, Felipe Serrano, Brett R. Blackman, Sanjay Sinha, Brian R. Wamhoff. Exposure of Induced Pluripotent Stem Cell‐Derived Vascular Endothelial and Smooth Muscle Cells in Coculture to Hemodynamics Induces Primary Vascular Cell‐Like PhenotypesSTEM CELLS Translational Medicine 2017; 6(8): 1673 doi: 10.1002/sctm.17-0004
12
M. Catarina Silva, Stephen J. Haggarty. Human pluripotent stem cell–derived models and drug screening in CNS precision medicineAnnals of the New York Academy of Sciences 2020; 1471(1): 18 doi: 10.1111/nyas.14012
13
Thomas K. Baker, Steven K. Engle, Bartley W. Halstead, Brianna M. Paisley, George H. Searfoss, Jeffrey A. Willy. Translating Molecules into MedicinesAAPS Advances in the Pharmaceutical Sciences Series 2017; 25: 119 doi: 10.1007/978-3-319-50042-3_5
14
Rosamaria Capuano, Paola Spitalieri, Rosa Valentina Talarico, Ana Carolina Domakoski, Alexandro Catini, Roberto Paolesse, Eugenio Martinelli, Giuseppe Novelli, Federica Sangiuolo, Corrado Di Natale. A preliminary analysis of volatile metabolites of human induced pluripotent stem cells along the in vitro differentiationScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-01790-5
15
Varun Khurana, Deep Kwatra, Sujay Shah, Abhirup Mandal, Ashim K. Mitra. Emerging Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices2017; : 85 doi: 10.1016/B978-0-323-42978-8.00005-X
16
M.C. Silva, A. Cross, N.J. Brandon, S.J. Haggarty. Comprehensive Medicinal Chemistry III2017; : 48 doi: 10.1016/B978-0-12-409547-2.12284-X
17
Tomaž Bratkovič, Janja Božič, Boris Rogelj. Functional diversity of small nucleolar RNAsNucleic Acids Research 2020; 48(4): 1627 doi: 10.1093/nar/gkz1140
18
Vincent L. Reynolds, Matthew M. Abernathy, Ronee B. Baracani, Javed A. Bhalli, LaRonda Morford, Meredith A. Steeves, Wei Wang. Burger's Medicinal Chemistry and Drug Discovery2021; : 1 doi: 10.1002/0471266949.bmc291
19
Paola Spitalieri, Rosa V. Talarico, Silvia Caioli, Michela Murdocca, Annalucia Serafino, Marco Girasole, Simone Dinarelli, Giovanni Longo, Sabina Pucci, Annalisa Botta, Giuseppe Novelli, Cristina Zona, Ruggiero Mango, Federica Sangiuolo. Modelling the pathogenesis of Myotonic Dystrophy type 1 cardiac phenotype through human iPSC-derived cardiomyocytesJournal of Molecular and Cellular Cardiology 2018; 118: 95 doi: 10.1016/j.yjmcc.2018.03.012
20
Claudia De Masi, Paola Spitalieri, Michela Murdocca, Giuseppe Novelli, Federica Sangiuolo. Application of CRISPR/Cas9 to human-induced pluripotent stem cells: from gene editing to drug discoveryHuman Genomics 2020; 14(1) doi: 10.1186/s40246-020-00276-2